- Home
- NWFL vs IMMX Comparison
NWFL vs IMMX Comparison
Compare NWFL & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWFL | IMMX |
|---|---|---|
| Founded | 1870 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.0M | 306.2M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NWFL | IMMX |
|---|---|---|
| Price | $28.55 | $10.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $33.00 | $16.33 |
| AVG Volume (30 Days) | 19.6K | ★ 666.7K |
| Earning Date | 04-22-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | N/A | ★ 14.61 |
| EPS | ★ 2.22 | N/A |
| Revenue | ★ $7,399,000.00 | N/A |
| Revenue This Year | $34.35 | N/A |
| Revenue Next Year | $5.55 | N/A |
| P/E Ratio | $13.00 | ★ N/A |
| Revenue Growth | ★ 3.69 | N/A |
| 52 Week Low | $21.25 | $1.34 |
| 52 Week High | $32.23 | $10.68 |
Technical Indicators
Market Signals| Indicator | NWFL | IMMX |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 77.52 |
| Support Level | $27.50 | $1.96 |
| Resistance Level | $29.58 | N/A |
| Average True Range (ATR) | 0.90 | 0.59 |
| MACD | -0.23 | 0.14 |
| Stochastic Oscillator | 5.21 | 88.14 |
Price Performance
Historical ComparisonAbout NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.